Published 6 days ago • loading... • Updated 6 days agoShow Less IconModerna stock falls ahead of cancer vaccine data (MRNA:NASDAQ) Summary by Seeking AlphaModerna (MRNA) stock sinks as investors await an Oct. 24 presentation containing additional Phase 3 data for its cancer shot developed with Merck (MRK). Read more here.Share menu1 Articles1 ArticlesAllLeftCenterRight1Search IconSort IconSeeking AlphaLean RightFactualityOwnershipModerna stock falls ahead of cancer vaccine data (MRNA:NASDAQ)Moderna (MRNA) stock sinks as investors await an Oct. 24 presentation containing additional Phase 3 data for its cancer shot developed with Merck (MRK). Read more here.6 days ago·Ra'anana, IsraelRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources1Leaning Left0Leaning Right1Center0Last Updated6 days agoBias Distribution100% RightBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources lean Right100% RightR 100%Factuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantageSeeking Alpha broke the news in Ra'anana, Israel 6 days ago on Friday, October 16, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsCambridge, Massachusetts Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsCambridge, Massachusetts Plus IconShow All